Ling Tong - Department of Medicinal Chemistry, Merck & Co., Inc

Idriss Bennacef, Zhizhen Zeng,Patricia Miller, Kerry Riffel,Mona Purcell, Hyking Haley, Xiangjun Meng, Yuchuan Wang,Anthony J. Roecker, A. Shaw, Craig A. Stump, Helen J. Mitchell,Ling Tong,Maria V. Fawaz, Robert E. Drolet,Ming Lei, Jacob Marcus,Wenping Li, Eric D. Hostetler

Alzheimer's & dementiano. S15 (2023)

Cited0Views0Bibtex

Discovery and Potential Application of [¹¹C]MK‐6884

Ling Tong,Wenping Li

Contemporary Accounts in Drug Discovery and Developmentpp.201-224, (2022)

Cited0Views0Bibtex

Discovery and Optimization of Potent, Selective, and Brain-Penetrant 1-Heteroaryl-1 H -Indazole LRRK2 Kinase Inhibitors for the Treatment of Parkinson's Disease

J Med Chem（2022）

Cited2Views0WOSBibtex

The Novel M4 PAM PET Tracer [11C] MK‐6884: a Novel Biomarker for Measuring Target Engagement of Muscarinic M4 Positive Allosteric Modulators (pams) As Well As Cholinergic Tone in Patients with Alzheimer’s Disease

Wenping Li,Anthony S Basile,Ling Tong,Koen Van Laere,Joseph C. Masdeu,Eric D Hostetler,Fiona Marshall,Jason M. Uslaner

Alzheimer's & dementia（2022）

Cited0Views0Bibtex

Discovery of [¹¹C]MK-6884: A Positron Emission Tomography (PET) Imaging Agent for the Study of M4Muscarinic Receptor Positive Allosteric Modulators (PAMs) in Neurodegenerative Diseases

Journal of medicinal chemistryno. 5 (2020): 2411-2425

Cited26Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn